Longevity Variant Database

Narrow results by variant, study, or associated fields (e.g. gene symbol ADRB2):

Use ontology terms to further narrow results (e.g. aging, insulin, etc.):


  • Variant effect: + -
  • Variant type: + -

  • 1 2 3 4 5 6 7 8 9 10 11 12
    13 14 15 16 17 18 19 20 21 X Y MT
    Export results (Download)

    Populations | Study Types | Variant Types



    LVDB_word_cloud.png
    logo.png
    variants.jpg
    polymorphism factor odds ratio pvalue initial number replication number Population age of cases shorter lived allele longer lived allele study type reference
    APOB XbaI − SI000565Q APOB 0.006 191 (case) vs 53 (initial) Chinese > 90 baseline, Mean age 97 +/- 3 X+ - Short X+ - Medium Candidate Region/Gene 17393087
    APOC3-SstI-RFLP (3'UTR, 3238 nt) APOC3 0.05 229 vs 571 Calabrian 81–109 (median 101) Candidate Region/Gene 12556235
    APOE e2,e3,e4 APOE 0.05 185 vs 486 Finn Over 100 E4 e2 Candidate Region/Gene 8018664
    APOE polymorphism APOE 0.437 1408 cases Brazilian 69.3 +/- 7.2 Candidate Region/Gene 17934638
    APOE polymorphism - HP1/2 common polymorphism APOE 0.013 200 (cases) vs 539 (initial) Italian >88 e4-H2 (haplotype) Candidate Region/Gene 21703254
    Arg156Arg ERCC2 0.05 149 vs 413 Polish Mean age 101.1 Candidate Region/Gene 19707883
    Asp312Asn ERCC2 0.05 149 vs 413 Polish Mean age 101.1 Candidate Region/Gene 19707883
    Cdx2-GATA haplotype 1 allele Vitamin D receptor 0.78 935 participants Dutch mean age = 75.7 years Candidate Region/Gene 21051524
    codon 192 PON1 1.0 192 vs 77 Italian 56 ages 66 to 89, 96 >90 Candidate Region/Gene 16799134
    codon 55 PON1 1.0 192 vs 77 Italian 56 ages 66 to 89, 96 >90 Candidate Region/Gene 16799134
    CTSD CTSD 1.0 224 vs 441 Ashkenazi Jewish 75 Candidate Region/Gene 15621215
    CYP2C19*1 (wt allele) / CYP2C19*2( rs4244285 / rs17878459 ) CYP2C19 1.21 0.2 239 vs 64 Danish 95 and over Candidate Region/Gene 9754988
    CYP2D6*3 CYP2D6 1.0 552 vs 243 French mean 101 Candidate Region/Gene 9654200
    CYP2D6*4 CYP2D6 1.0 523 vs 252 French mean 101 Candidate Region/Gene 9654200
    DRD4 DRD4 1.0 224 vs 441 Ashkenazi Jewish 75 Candidate Region/Gene 15621215
    GSTM1 deletion GSTM1 1.0 565 vs 229 French mean 101 Candidate Region/Gene 9654200
    H63D HFE 1.0 35 vs 106 91-105 Candidate Region/Gene 11857056
    HP*1 F/S HP 0.82 0.33 1072 total Italian >88 Candidate Region/Gene 21147083
    HP1/2 common polymorphism HP 0.05 200 (cases) vs 539 (initial) (initial) Italian >88 Candidate Region/Gene 21703254
    HRAS1 LASS1 (CCT) APOE 4.1e-05 147 vs 188 Georgian Candidate Region/Gene 20569235
    HRAS1 LASS1 (CCT) APOE 9.5e-05 204 vs 251 American Candidate Region/Gene 20569235
    HRAS1 LASS1 (CCT) APOE 1e-05 128 vs 115 Georgian Candidate Region/Gene 20569235
    HRAS1 LASS1 (CCT) APOE 0.00197 125 vs 163 American Candidate Region/Gene 20569235
    HRAS1 LASS1 (CCT) APOE 0.0511 68 vs 68 American Candidate Region/Gene 20569235
    HRAS1 LASS1 (CGT) APOE 7.8e-05 147 vs 188 Georgian Candidate Region/Gene 20569235

    The Longevity Variant Database (LVDB) is a collaborative effort to catalogue all published genetic variants relevant to human longevity.

    The project is directed by the Health Extension Research Foundation [http://www.healthextension.co/about/], and the online content is managed by the members of the Global Computing Initiative.

    LVDB is driven by an international collaboration of scientists, programmers, and volunteers, including Joe Betts-LaCroix, Kristen Fortney, Daniel Wuttke, Eric K. Morgen, Nick Schaum, John M. Adams, Jessica Choi, Barry Goldberg, Amir Levine, Maria Litovchenko, Aiste Narkeviciute, Emily Quist, Navneet Ramesh, Justin Rebo, Dmitri Shytikov, and Jimi Vyas. o


    Suggest a new study Report a database issue